ABCM Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 des 2023 @ 22:00):

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery...

Stats
Dagens volum	7.43M
Gjennomsnittsvolum	5.82M
Markedsverdi	5.52B
EPS	£0.0361 ( 2023-08-31 )
Last Dividend	£0.0443 ( 2020-03-19 )
Next Dividend	£0 ( N/A )
P/E	2 399.00
ATR14	£0.166 (0.69%)

Volum Korrelasjon

Lang: -0.08 (neutral)

Kort: 0.00 (neutral)

Signal:(73.195) Neutral

Abcam plc Korrelasjon

10 Mest positive korrelasjoner
MSAC	0.953
KAII	0.95
MLAI	0.95
QUIK	0.947
CAR	0.946
BTBT	0.944
GGAL	0.944
LGAC	0.943
ALSA	0.943
NVSA	0.94

10 Mest negative korrelasjoner
PRPO	-0.962
PSCH	-0.955
PSCC	-0.942
VORB	-0.942
VIVE	-0.938
PRFZ	-0.938
PTH	-0.937
PNQI	-0.935
ORPH	-0.935
SENEA	-0.932

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Abcam plc Korrelasjon - Valuta/Råvare

0.11
( neutral )

0.63
( weak )

0.00
( neutral )

0.04
( neutral )

0.17
( neutral )

-0.72
( moderate negative )

Abcam plc Økonomi

Annual	2022
Omsetning:	£361.70M
Bruttogevinst:	£270.50M (74.79 %)
EPS:	£-0.0372

FY	2022
Omsetning:	£361.70M
Bruttogevinst:	£270.50M (74.79 %)
EPS:	£-0.0372

FY	2021
Omsetning:	£297.70M
Bruttogevinst:	£211.80M (71.15 %)
EPS:	£0.0780

Financial Reports:

No articles found.

Abcam plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Abcam plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.72 - No dividend growth expected in the near future

Information

First Dividend	£0.0358	2014-03-19
Last Dividend	£0.0443	2020-03-19
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	£0.836	--
Avg. Dividend % Per Year	0.02%	--
Score	3.14	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.72
Div. Directional Score	6.68	--

Next Divdend (Est)
(2024-08-19)

£0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

3.14

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2014	£0.122	1.59%
2015	£0.124	1.78%
2016	£0.117	1.23%
2017	£0.114	1.26%
2018	£0.158	1.12%
2019	£0.157	1.10%
2020	£0.0443	0.24%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.000600	1.500	9.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0.000268	1.200	9.99	10.00	[0 - 0.3]
returnOnEquityTTM	0.000380	1.500	-1.107	-1.660	[0.1 - 1]
payoutRatioTTM	22.73	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.354	0.800	8.23	6.58	[1 - 3]
quickRatioTTM	0.993	0.800	8.86	7.09	[0.8 - 2.5]
cashRatioTTM	0.418	1.500	8.79	10.00	[0.2 - 2]
debtRatioTTM	0.211	-1.500	6.48	-9.72	[0 - 0.6]
interestCoverageTTM	9.21	1.000	7.70	7.70	[3 - 30]
operatingCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.302	-1.500	8.79	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.779	1.000	0.352	0.352	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.121	1.000	-0.440	-0.440	[0.2 - 2]
assetTurnoverTTM	0.446	0.800	-0.360	-0.288	[0.5 - 2]
Total Score				10.65

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	16 180	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.000380	2.50	-0.712	-1.660	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
payoutRatioTTM	22.73	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-68.63	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0572	1.000	-1.070	0	[0.1 - 0.5]
Total Score				2.72

Abcam plc

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.